Published in J Invest Dermatol on June 15, 2015
Recent advances in understanding ichthyosis pathogenesis. F1000Res (2016) 0.78
In silico predicted structural and functional insights of all missense mutations on 2B domain of K1/K10 causing genodermatoses. Oncotarget (2016) 0.75
Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma. Am J Hum Genet (2017) 0.75
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res (2014) 8.86
A structural scaffolding of intermediate filaments in health and disease. Science (1998) 4.70
'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol (2002) 3.00
The cDNA sequence of a Type II cytoskeletal keratin reveals constant and variable structural domains among keratins. Cell (1983) 2.92
Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science (2010) 2.21
The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat (2008) 1.97
An unexpected role for keratin 10 end domains in susceptibility to skin cancer. J Cell Sci (2006) 1.64
Consequences of two different amino-acid substitutions at the same codon in KRT14 indicate definitive roles of structural distortion in epidermolysis bullosa simplex pathogenesis. J Invest Dermatol (2011) 1.53
Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice. J Cell Sci (2002) 1.28
Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell (2005) 1.23
Structural basis for heteromeric assembly and perinuclear organization of keratin filaments. Nat Struct Mol Biol (2012) 1.10
Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol (2011) 1.08
Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol (2001) 1.07
The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J Biol Chem (2002) 1.02
Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis. J Invest Dermatol (1994) 0.95
The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol (1998) 0.94
Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol (2006) 0.93
Evidence against keratin gene mutations in a family with ichthyosis hystrix Curth-Macklin. J Invest Dermatol (1993) 0.93
Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nat Biotechnol (2000) 0.92
Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. J Clin Invest (1994) 0.91
Altered keratin expression in ichthyosis hystrix Curth-Macklin. A light and electron microscopic study. Arch Dermatol Res (1990) 0.91
A novel three-nucleotide deletion in the helix 2B region of keratin 14 in epidermolysis bullosa simplex: delta E375. Hum Mol Genet (1993) 0.89
Retinoids reduce formation of keratin aggregates in heat-stressed immortalized keratinocytes from an epidermolytic ichthyosis patient with a KRT10 mutation*. Acta Derm Venereol (2013) 0.87
Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet (1994) 0.85
A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes. J Invest Dermatol (2001) 0.85
Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol (2006) 0.83
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol (2011) 0.82
Analysis of sequences controlling tissue-specific and hyperproliferation-related keratin 6 gene expression in transgenic mice. DNA Cell Biol (1998) 0.81
Easy method for keratin 14 gene amplification to exclude pseudogene sequences: new keratin 5 and 14 mutations in epidermolysis bullosa simplex. J Invest Dermatol (2008) 0.80
Epidermolytic hyperkeratosis: applied molecular genetics. J Invest Dermatol (1994) 0.78
New KRT10 gene mutation underlying the annular variant of bullous congenital ichthyosiform erythroderma with clinical worsening during pregnancy. Br J Dermatol (2007) 0.78
The ends of a conundrum? J Cell Sci (2007) 0.78
Ichthyosis hystrix Lambert type and Curth-Macklin type are a single entity with affected (KRT1 mutation) or unaffected (KRT10 mutation) palms and soles? Eur J Dermatol (2016) 0.77
Novel KRT14 mutation in a Taiwanese patient with epidermolysis bullosa simplex (Köbner type). J Formos Med Assoc (2002) 0.77
Long-range polymerase chain reaction for specific full-length amplification of the human keratin 14 gene and novel keratin 14 mutations in epidermolysis bullosa simplex patients. J Invest Dermatol (2003) 0.77
Novel mutation of the KRT 10 gene in a Japanese patient with epidermolytic hyperkeratosis. J Dermatol (2011) 0.77
Mild phenotype of epidermolytic hyperkeratosis mimicking ichthyosis bullosa of Siemens is related to specific mutation in 2B domain of KRT1. J Dermatol Sci (2013) 0.77
IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome. J Allergy Clin Immunol (2014) 0.78